Acasă › Cancer metastatic › Utah › Salt Lake City
Studii clinice pentru Cancer metastatic în Salt Lake City, UT
20 studii pentru Cancer metastatic caută participanți în și în jurul orașului Salt Lake City (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
În curs de recrutareFaza 1
- University of Utah - Huntsman Cancer Institute, Salt Lake City
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
În curs de recrutareFaza 1
- Intermountain Health, Salt Lake City
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
În curs de recrutareFaza 2/3
- Huntsman Cancer Institute, University of Utah, Salt Lake City
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
În curs de recrutareFaza 1/2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
În curs de recrutareFaza 3
- Huntsman Cancer Institute, University of Utah, Salt Lake City
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
În curs de recrutareFaza 3
- Huntsman Cancer Institute, Salt Lake City
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
În curs de recrutareFaza 3
- Utah Cancer Specialists, Salt Lake City
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
În curs de recrutareFaza 1/2
- University of Utah - Huntsman Cancer Institute, Salt Lake City
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
În curs de recrutareFaza 1
- University of Utah, Salt Lake City
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
În curs de recrutareFaza 1
- Huntsman Cancer Institute/University of Utah, Salt Lake City
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
În curs de recrutareFaza 1/2
- Crinetics Study Site, Salt Lake City
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
În curs de recrutareFaza 1/2
- Utah Cancer Specialists, Salt Lake City
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
În curs de recrutareFaza 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
În curs de recrutareFaza 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
În curs de recrutareFaza 1
- Huntsman Cancer Institute, Salt Lake City
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
În curs de recrutareFaza 1/2
- Huntsman Cancer Institute, Salt Lake City
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
În curs de recrutareFaza 1/2
- Huntsman Cancer Institute, Salt Lake City
Topical Tretinoin Prophylaxis for Anti-EGFR Induced Skin Toxicity in Patients With Solid Tumors
În curs de recrutareFaza 2
- Huntsman Cancer Institute at University of Utah, Salt Lake City
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
În curs de recrutareFaza 1/2
- Utah Cancer Specialists (site 203), Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
În curs de recrutareStudiu observațional
- Massive Bio SYNERGY-AI site, Salt Lake City
Studii pentru Cancer metastatic în alte orașe
- Houston, TX104 studii
- New York City, NY93 studii
- Nashville, TN70 studii
- Boston, MA63 studii
- Los Angeles, CA57 studii
- St. Louis, MO54 studii
- Arlington, VA53 studii
- Philadelphia, PA46 studii
- Chicago, IL45 studii
- San Antonio, TX44 studii
- Washington, DC43 studii
- Dallas, TX42 studii
Alte studii în Salt Lake City
- Cancer pulmonar cu celule non-pătrate31 studii
- Cancer (toate tipurile)27 studii
- Cancer de sân27 studii
- Cancer colorectal22 studii
- Cancer pulmonar21 studii
- Melanom21 studii
- Mielom multiplu21 studii
- Cancer ovarian19 studii
- Obezitate18 studii
- Leucemie mieloasă acută17 studii
- Insuficiență cardiacă17 studii
- Cancer de prostată15 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.